Matinas

MTNB AMEX
0.7200
-0.0253
-3.39%
Closed 16:00 07/19 EDT
Open
0.7365
Prev Close
0.7453
High
0.7698
Low
0.7000
Volume
541.15K
Avg Vol (3M)
765.09K
52 Week High
1.500
52 Week Low
0.3450
% Turnover
0.38%
Market Cap
102.95M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Matinas MTNB stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Matinas BioPharma Holdings, Inc., is a development stage biopharmaceutical company. The Company focuses on identifying and developing novel pharmaceutical products. The Company's technology utilizes lipid-crystal nano-particle cochleates to nano-encapsulate existing drugs, which is designed to make safer, more tolerable, less toxic and orally bioavailable. The Company's technology combines the use of lipids as active pharmaceutical ingredients (APIs) and the use of lipids in cochleate-shaped lipid-crystal nano-particle drug delivery vehicles. The Company’s product candidates include, MAT2203 and MAT2501.The Company's anti-infective product candidate, MAT 2203, is an application of its cochleate delivery technology to a spectrum anti-fungal drug called amphotericin B. The Company's MAT2501 is an orally administered, encochleated formulation of the spectrum IV-only aminoglycoside antibiotic agent amikacin, utilizes the Company's lipid-crystal, nanoparticle delivery technology.
MORE >

Recently

Name
Price
%Change